Chandigarh, January 1, 2026 – Nectar Lifesciences Limited (NECLIFE) witnessed a sharp pickup in participation in its ongoing share buyback, with the issue subscribed
0.33 times as of
12:30 p.m. on January 1, 2026, driven largely by strong interest from individual investors.
The company is undertaking a
fixed-price buyback of up to
3 crore equity shares at an offer price of
₹27 per share, with the buyback window open from
December 31, 2025 to January 6, 2026.
Buyback Overview
| Particulars | Details |
|---|
| Company | Nectar Lifesciences Limited |
| Symbol | NECLIFE |
| Series | BB |
| Offer Type | Buyback |
| Issue Type | Fixed Price |
| Offer Price | ₹27 per equity share |
| Face Value | ₹1 |
| Issue Size | Up to 3,00,00,000 equity shares |
| Offer Period | December 31, 2025 – January 6, 2026 |
| Market Lot | 1 equity share |
| Market Timings | 9:15 a.m. to 3:30 p.m. |
Subscription Status
(As on January 1, 2026 | 12:30 p.m.)| Category | Shares Bid |
|---|
| Qualified Institutional Buyers (QIBs) | 1,26,850 |
| Non-Institutional Investors | 1,46,651 |
| Individual Investors | 94,85,440 |
| Total | 97,58,941 |
Against the total offer size of
3 crore shares, bids for
97.59 lakh shares have been received so far, translating into an overall subscription of
0.33 times.
Category-wise Demand Trend
Retail Investors Drive Momentum
Individual investors accounted for the overwhelming majority of bids, with demand for
94.86 lakh shares, indicating sustained retail participation as the buyback progresses.
Gradual Institutional Participation
Interest from the institutional segment showed improvement compared to the previous day, with QIBs bidding for
1.27 lakh shares, while corporates under the non-institutional category bid for
1.47 lakh shares.
Price-wise Order Book
| Offer Price (₹) | No. of Orders | Demat Quantity | Physical Quantity | Total Quantity |
|---|
| 27.00 | 2,645 | 97,58,941 | – | 97,58,941 |
All bids received so far have been placed in dematerialised form, with no physical share tenders reported.
Offer Management Details
| Particulars | Information |
|---|
| Acquirer | Nectar Lifesciences Limited |
| Book Running Lead Manager | Master Capital Services Limited |
| Registrar | KFin Technologies Limited |
| Registrar Address | Selenium, Tower B, Plot Nos. 31 & 32, Gachibowli, Financial District, Nanakramguda, Serilingampally Mandal, Hyderabad – 500032 |
| Contact Person | M. Murali Krishna |
| Phone | +91 40 6716 2222 / 18003094001 |
| Email | nectar.buyback@kfintech.com |
